The antibody 34bE12, available from A Menarini Diagnostics, recognises cytokeratin 1, 5, 10 and 14. It reacts with squamous and adenosquamous cell carcinomas, while adenocarcinoma is negative. In normal tissue, 34bE12 stains stratified epithelia, myoepithelial cells and basal cells in the prostate gland and bronchus. Thus, it is useful as a differential marker for squamous carcinoma and adenocarcinoma as well as for benign and malignant tumours of the prostate gland.
Other News
Featured Supplier
Your partner for equipment and consumables for medicine and science
Sarstedt, one of the world's leading providers of laboratory and medical equipment, develops, manufactures and sells equipment and consumables in the field of medicine and science.
Founded in 1961, the company has continued to grow to the point where it now employs a...
Upcoming Events
EQA Reports: Interpreting Key Information & Troubleshooting Tips
ONLINE - Zoom
16 May, 2024
Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy
Sheffield Hallam University, City Campus, Howard Street, Sheffield
24 May, 2024
Med-Tech Innovation Expo
NEC, Birmingham
5-6 June, 2024
UK NEQAS Blood Coagulation: Clinical and Laboratory Haemostasis 2024
Sheffield Hallam University
5-6 June, 2024
LabMedUK24
DoubleTree by Hilton Brighton Metropole
10-12 June, 2024
Infection Diagnostics Symposium 2024
IET Austin Court, Birmingham
26-27 June, 2024
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store